Tristel Plc engages in the design, development, manufacture, and sale of infection control, contamination control and hygiene products. The company is headquartered in Snailwell, Cambridgeshire and currently employs 238 full-time employees. The company went IPO on 2005-06-01. The firm's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The firm operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. The company manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The firm also manufactures and sells hospital environmental surface disinfection products. The firm is also focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.